The link between obesity and low circulating 25-hydroxyvitamin D concentrations: Considerations and implications

International Journal of Obesity

Volumn 36, Issue 3, 2012, Pages 387-396

  Earthman, C P ^a   Beckman, L M ^a   Masodkar, K ^a   Sibley, S D ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

adipose; deficiency; inadequacy; insufficiency; vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; COLECALCIFEROL;

ADIPOSE TISSUE; BARIATRIC SURGERY; DISEASE ASSOCIATION; HUMAN; MALABSORPTION; MOLECULAR MECHANICS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

BARIATRIC SURGERY; FEMALE; HUMANS; MALE; OBESITY, MORBID; PUBLIC HEALTH; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84858297008     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.119     Document Type: Review

References (108)

1. Popkin BM. Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr 2010; 91: 284S-288S.
2. Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA, Gerstein HC et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab 2011; 96: 168-175.
3. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26: 573-580. (Pubitemid 47618319)
4. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006; 12: 62-66. (Pubitemid 43050076)
5. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008; 16: 2323-2330.
6. Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg 2009; 19: 1605-1611.
7. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
8. Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine: Washington, DC, 2010.
9. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2010; 128: 1414-1424.
10. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 2009; 4: 1515-1522.
11. Ozfirat Z, Chowdhury TA. Vitamin D deficiency and type 2 diabetes. Postgrad Med J 2010; 86: 18-25.
12. Foss YJ. Vitamin D deficiency is the cause of common obesity. Med Hypotheses 2009; 72: 314-321.
13. Osei K. 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes? J Clin Endocrinol Metab 2010; 95: 4220-4222.
14. Bischoff-Ferrari H. Health effects of vitamin D. Dermatol Ther 2010; 23: 23-30.
15. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86: 888-894. (Pubitemid 32207511)
16. Wood RJ. Vitamin D and adipogenesis: new molecular insights. Nutr Rev 2008; 66: 40-46. (Pubitemid 351666660)
17. Kamei Y, Kawada T, Kazuki R, Ono T, Kato S, Sugimoto E. Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 1993; 193: 948-955. (Pubitemid 23209686)
18. Querfeld U, Hoffmann MM, Klaus G, Eifinger F, Ackerschott M, Michalk D et al. Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. J Am Soc Nephrol 1999; 10: 2158-2164. (Pubitemid 29453493)
19. Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK et al. 1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 2008; 112: 122-126.
20. Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008; 57: 183-191.
21. Carlin AM, Rao DS, Meslemani AM, Genaw JA, Parikh NJ, Levy S et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 98-103.
22. Ernst B, Thurnheer M, Schmid SM, Schultes B. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19: 66-73.
23. Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 2006; 10: 1033-1037. (Pubitemid 44037477)
24. Jin J, Stellato TA, Hallowell PT, Schuster M, Graf K, Wilhelm S. Utilization of preoperative patient factors to predict postoperative vitamin D deficiency for patients undergoing gastric bypass. J Gastrointest Surg 2009; 13: 1052-1057.
25. Mahlay NF, Verka LG, Thomsen K, Merugu S, Salomone M. Vitamin D status before Roux-en-Y and efficacy of prophylactic and therapeutic doses of vitamin D in patients after Roux-en-Y gastric bypass surgery. Obes Surg 2009; 19: 590-594.
26. Stein EM, Strain G, Sinha N, Ortiz D, Pomp A, Dakin G et al. Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin Endocrinol (Oxf) 2009; 71: 176-183.
27. Signori C, Zalesin KC, Franklin B, Miller WL, McCullough PA. Effect of gastric bypass on vitamin D and secondary hyperparathyroidism. Obes Surg 2010; 20: 949-952.
28. Vilarrasa N, Maravall J, Estepa A, Sanchez R, Masdevall C, Navarro MA et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007; 30: 653-658. (Pubitemid 350104094)
29. Brock K, Huang WY, Fraser DR, Ke L, Tseng M, Stolzenberg-Solomon R et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol 2010; 121: 462-466.
30. Aasheim E, Hofs D, Hjelmesaeth J, Birkeland K, Bhmer T. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 2008; 87: 362-369. (Pubitemid 351226072)
31. Chai W, Conroy S, Maskarinec G, Franke A, Pagano I, Cooney R. Associations between obesity and serum lipid-soluble micronutrients among premenopausal women. Nutr Res 2010; 30: 227-232.
32. Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251-4257.
33. Flores L, Osaba MJ, Andreu A, Moize V, Rodriguez L, Vidal J. Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism. Obes Surg 2010; 20: 738-743.
34. Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)Fa prospective study. Obesity Surg 2010; 20: 447-453.
35. Goldner WS, Stoner JA, Thompson J, Taylor K, Larson L, Erickson J et al. Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls. Obes Surg 2008; 18: 145-150.
36. Granado-Lorencio F, Simal-Anton A, Salazar-Mosteiro J, Herrero-Barbudo C, Donoso-Navarro E, Blanco-Navarro I et al. Timecourse changes in bone turnover markers and fat-soluble vitamins after obesity surgery. Obes Surg 2010; 20: 1524-1529.
37. Khandalavala BN, Hibma PP, Fang X. Prevalence and persistence of vitamin D deficiency in biliopancreatic diversion patients: a retrospective study. Obes Surg 2010; 20: 881-884.
38. Fish E, Beverstein G, Olson D, Reinhardt S, Garren M, Gould J. Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res 2010; 164: 198-202.
39. Compher CW, Badellino KO, Boullata JI. Vitamin D and the bariatric surgical patient: a review. Obes Surg 2008; 18: 220-224.
40. Bischof MG, Heinze G, Vierhapper H. Vitamin D status and its relation to age and body mass index. Horm Res 2006; 66: 211-215. (Pubitemid 44597718)
41. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7: 4.
42. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 2010; 18: 1906-1910.
43. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89: 1196-1199. (Pubitemid 38368412)
44. Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G. Crosssectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr 2010; 49: 401-407.
45. Vilarrasa N, Vendrell J, Maravall J, Elo I, Solano E, San Jos P et al. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 2010; 38: 235-242.
46. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin H et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009; 280: 559-563.
47. Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab 2009; 94: 67-73.
48. Beydoun MA, Boueiz A, Shroff MR, Beydoun HA, Wang Y, Zonderman AB. Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 2010; 95: 3814-3827.
49. Valina-Toth AL, Lai Z, Yoo W, Abou-Samra A, Gadegbeku CA, Flack JM. Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) 2010; 72: 595-603.
50. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 2009; 94: 3306-3313.
51. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010; 59: 242-248.
52. Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010; 95: 1076-1083.
53. Yanoff LB, Parikh SJ, Spitalnik A, Denkinger B, Sebring NG, Slaughter P et al. The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) 2006; 64: 523-529.
54. Winters SJ, Chennubhatla R, Wang C, Miller JJ. Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism 2009; 58: 438-442.
55. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4-8. (Pubitemid 43831956)
56. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88: 491S-499S.
57. Rueda S, Fernandez-Fernandez C, Romero F, Martinez de Osaba J, Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008; 18: 151-154.
58. Clements RH, Yellumahanthi K, Wesley M, Ballem N, Bland KI. Hyperparathyroidism and vitamin D deficiency after laparoscopic gastric bypass. Am Surg 2008; 74: 469-474. (Pubitemid 351768748)
59. Lagunova Z, Porojnicu AC, Vieth R, Lindberg FA, Hexeberg S, Moan J. Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. J Nutr 2011; 141: 112-117.
60. Frost M, Abrahamsen B, Nielsen TL, Hagen C, Andersen M, Brixen K. Vitamin D status and PTH in young men: a crosssectional study on associations with bone mineral density, body composition and glucose metabolism. Clin Endocrinol (Oxf) 2010; 73: 573-580.
61. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R. Serum 1, 25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008; 47: 87-91.
62. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693. (Pubitemid 30667088)
63. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J et al. Vitamin D(3) in fat tissue. Endocrine 2008; 33: 90-94.
64. Lin E, Armstrong-Moore D, Liang Z, Sweeney JF, Torres WE, Ziegler TR et al. Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity (Silver Spring) 2010; 19: 588-594.
65. Aasheim ET, Bjorkman S, Sovik TT, Engstrom M, Hanvold SE, Mala T et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr 2009; 90: 15-22.
66. Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251-4257.
67. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17: 517-524. (Pubitemid 47176859)
68. Kull M, Kallikorm R, Lember M. Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J 2009; 39: 256-258.
69. Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S. Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol 2007; 103: 679-681. (Pubitemid 46401323)
70. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a proinflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007; 77: 47-57. (Pubitemid 46590467)
71. Compher C, Badellino KO. Obesity and inflammation: lessons from bariatric surgery. J Parenter Enteral Nutr 2008; 32: 645-647.
72. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010-1013. (Pubitemid 46525079)
73. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94: 4023-4030.
74. 2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687-698.
75. Jorde R, Sneve M, Torjesen PA, Figenschau Y, Goransson LG, Omdal R. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 2010; 50: 175-180.
76. Rayalam S, Della-Fera MA, Ambati S, Yang JY, Park HJ, Baile CA. Enhanced effects of 1,25(OH)(2)D(3) plus genistein on adipogenesis and apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring) 2008; 16: 539-546. (Pubitemid 351328003)
77. Kong J, Li YC. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006; 290: E916-E924.
78. Vieth R. Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of 'free' 1,25-dihydroxyvitamin D. Clin Chem 1994; 40: 435-441.
79. Gonzales AM, Orlando RA. Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr Metab (Lond) 2007; 4: 22.
80. Dani C, Amri EZ, Bertrand B, Enerback S, Bjursell G, Grimaldi P et al. Expression and regulation of pOb24 and lipoprotein lipase genes during adipose conversion. J Cell Biochem 1990; 43: 103-110. (Pubitemid 20184302)
81. Tontonoz P, Kim JB, Graves RA, Spiegelman BM. ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993; 13: 4753-4759.
82. LefterovaMI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008; 22: 2941-2952.
83. Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD et al. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev 1989; 3: 1323-1335.
84. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-1234.
85. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79: 1147-1156.
86. Freytag SO, Geddes TJ. Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Science 1992; 256: 379-382.
87. Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z et al. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 2009; 296: E820-E828.
88. Boon N, Hul GB, Sicard A, Kole E, Van Den Berg ER, Viguerie N et al. The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity (Silver Spring) 2006; 14: 1739-1746. (Pubitemid 46214796)
89. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH et al. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose toleranceFa prospective randomized double-blind study. Acta Med Scand 1987; 222: 361-367. (Pubitemid 18049118)
90. Ortega RM, Lopez-Sobaler AM, Aparicio A, Bermejo LM, Rodriguez-Rodriguez E, Perea JM et al. Vitamin D status modification by two slightly hypocaloric diets in young overweight/obese women. Int J Vitam Nutr Res 2009; 79: 71-78.
91. Teegarden D, White KM, Lyle RM, Zemel MB, Van Loan MD, Matkovic Vet al. Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 2008; 16: 1566-1572. (Pubitemid 351915103)
92. Chan She Ping-DelfosW, Soares M. Diet induced thermogenesis, fat oxidation and food intake following sequential meals: Influence of calcium and vitamin D. Clinical Nutrition 2011; 30: 376-383.
93. Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008; 159: 675-684.
94. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321-1327.
95. McCarty MF, Thomas CA. PTH excess may promote weight gain by impeding catecholamine-induced lipolysisFimplications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003; 61: 535-542. (Pubitemid 37411898)
96. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J 2000; 14: 1132-1138. (Pubitemid 30350395)
97. Zemel MB. Mechanisms of dairy modulation of adiposity. J Nutr 2003; 133: 252S-256S. (Pubitemid 36070612)
98. Holecki M, Zahorska-Markiewicz B, Wiecek A, Mizia-Stec K, Nieszporek T, Zak-Golab A. Influence of calcium and vitamin D supplementation on weight and fat loss in obese women. Obes Facts 2008; 1: 274-279.
99. Shahar D, Schwarzfuchs D, Fraser D, Vardi H, Thiery J, Fiedler G et al. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr 2010; 92: 1017-1022.
100. Carlin AM, Rao DS, Yager KM, Genaw JA, Parikh NJ, Szymanski W. Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis 2006; 2: 638-642. (Pubitemid 44804160)
101. Gasteyger C, Suter M, Gaillard RC, Giusti V. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr 2008; 87: 1128-1133. (Pubitemid 351679749)
102. Madan AK, Orth WS, Tichansky DS, Ternovits CA. Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg 2006; 16: 603-606. (Pubitemid 43781045)
103. Pajecki D, Dalcanalle L, Souza de Oliveira CP, Zilberstein B, Halpern A, Garrido Jr AB et al. Follow-up of Roux-en-Y gastric bypass patients at 5 or more years postoperatively. Obes Surg 2007; 17: 601-607. (Pubitemid 46945417)
104. Carlin AM, Yager KM, Rao DS. Vitamin D depletion impairs hypertension resolution after Roux-en-Y gastric bypass. Am J Surg 2008; 195: 349-352. (Pubitemid 351625117)
105. Norman AW, Deluca HF. The preparation of H3-vitamins D2 and D3Ftheir localization in the rat. Biochemistry 1963; 2: 1160-1168.
106. Schachter D, Finkelstein JD, Kowarski S. Metabolism of vitamin D. I. Preparation of radioactive vitamin D and its intestinal absorption in the rat. J Clin Invest 1964; 43: 787-796.
107. GoldnerWS, Stoner JA, Lyden E, Thompson J, Taylor K, Larson L et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg 2009; 19: 173-179.
108. Williams SE. Bariatric surgery and skeletal health. www.osteo porosissymptoms.org/cmexam/Issue19BariatricSurgery/bariatric. htm 2010.